Series focuses on stressed rural hospitals that may need to close

Leave a reply

About Joseph Burns

Joseph Burns (@jburns18), a Massachusetts-based independent journalist, is AHCJ’s topic leader on health insurance. He welcomes questions and suggestions on insurance resources and tip sheets at joseph@healthjournalism.org.

empty-hospital

Photo: Naoki Takano via Flickr

Given all the concern about the failure of rural hospitals, it may seem counterintuitive that some hospitals in rural America may need to close. In multipart series for the Atlanta Journal-Constitution, investigative news reporter Yamil Berard found last year that some rural hospitals in Georgia had serious deficiencies.

Those deficiencies included significantly low occupancy rates, stiff competition from other hospitals, dwindling populations in their service areas, poor management and faulty decision-making, she reported. Continue reading →

Reporter shares how pandemic has sharpened her remote interviewing skills

Leave a reply

About Bara Vaida

Bara Vaida (@barav) is AHCJ's core topic leader on infectious diseases. An independent journalist, she has written extensively about health policy and infectious diseases. Her work has appeared in outlets that include the National Journal, Agence France-Presse, Bloomberg News, McClatchy News Service, MSNBC, NPR, Politico and The Washington Post.

Photo: Bill Dickinson via Flickr

Reporting feature stories about COVID-19 and its impact on Americans is more critical and more challenging than ever.

These stories usually would involve dozens of hours of in-person interviews; something journalists won’t be able to do for many months to come. What kinds of stories should we tell in our communities and how can we report them?

Jessica Contrera, a writer for the local enterprise team at The Washington Post, has some ideas for journalists, including tips on reporting from a distance, getting people to open up and tell their stories in detail and interesting angles to explore.

Continue reading →

New resources for covering the virus that’s changed our world

Leave a reply

About Bara Vaida

Bara Vaida (@barav) is AHCJ's core topic leader on infectious diseases. An independent journalist, she has written extensively about health policy and infectious diseases. Her work has appeared in outlets that include the National Journal, Agence France-Presse, Bloomberg News, McClatchy News Service, MSNBC, NPR, Politico and The Washington Post.

COVID-backgrounder

Photo: Babette Plana via Flickr

What a year it’s been for health care journalism to shine.

On Jan. 5, 2020, the World Health Organization issued a press release announcing a pneumonia of “unknown-cause” was circulating in Wuhan, China. By mid-January, Chinese scientists identified the cause as a coronavirus, eventually dubbed SARS-CoV-2, and publicly shared the virus’s genetic sequence. The disease caused by the virus was named COVID-19. Continue reading →

Does care suffer as private equity firms buy struggling nursing homes?

Leave a reply

About Liz Seegert

Liz Seegert (@lseegert), is AHCJ’s topic editor on aging. Her work has appeared in NextAvenue.com, Journal of Active Aging, Cancer Today, Kaiser Health News, the Connecticut Health I-Team and other outlets. She is a senior fellow at the Center for Health Policy and Media Engagement at George Washington University and co-produces the HealthCetera podcast.

NursingPrivateEquity_Blog_Aging_Seegert-50401413923_cef0234a0f_c

Photo: Gilbert Mercier via Flickr

Private equity firms are in the business of making money. On the surface, there is nothing wrong with that. However, a disturbing story in The Washington Post alleges that when private equity is involved in the buying and selling of nursing homes, things are often worse than they seem.

The story, by reporters Rebecca Tan and Rachel Chason, looks at Portopiccolo Group, which has a history of buying one- and two-star rated facilities. Continue reading →

Get a chance to further your health journalism knowledge through AHCJ fellowships

Leave a reply

About Pia Christensen

Pia Christensen (@AHCJ_Pia) is the managing editor/online services for AHCJ. She manages the content and development of healthjournalism.org, coordinates AHCJ's social media efforts and edits and manages production of association guides, programs and newsletters.

The 2011 AHCJ-CDC Health Journalism Fellows met with Ali S. Khan, M.D., M.P.H., assistant surgeon general and director of the CDC's Office of Public Health Preparedness and Response.

The 2011 AHCJ-CDC Health Journalism Fellows met with Ali S. Khan, M.D., M.P.H., assistant surgeon general and director of the CDC’s Office of Public Health Preparedness and Response.

AHCJ is taking applications for two of its premier fellowship programs: the AHCJ-CDC Health Journalism Fellowships and the AHCJ Reporting Fellowships on Health Care Performance.

Both programs offer journalists a chance to receive top training and a chance to find new sources and story ideas for their reporting. Continue reading →

NIH director, pandemic expert discuss development, rollout of COVID-19 vaccines

Leave a reply

About Pia Christensen

Pia Christensen (@AHCJ_Pia) is the managing editor/online services for AHCJ. She manages the content and development of healthjournalism.org, coordinates AHCJ's social media efforts and edits and manages production of association guides, programs and newsletters.

NIH director speaks to AHCJ Summit on Infectious DiseasesWhile describing the efforts of the National Institutes of Health and its partnerships with other agencies and pharmaceutical companies, NIH Director Francis Collins described the endeavor as “the most amazing outpouring of scientific capabilities, determination, talent that I’ve ever seen in my 27 years at NIH.”

During a recorded keynote speech at AHCJ’s Journalism Summit on Infectious Disease on Nov. 18, Collins said “The news [about recently announced vaccine trials] is extremely good. Both of these involving trials of 30,000 or more participants have been able to show that the messenger RNA-based vaccine strategy has resulted in over 90% efficacy for both of these and what appears to be a very reasonable safety record as well.” Continue reading →